The Food and Drug Administration approved an implantable lens made by Ophtec USA Inc. on Monday. The new lens is for people who have moderate to extreme nearsightedness and for people that are not able to have Lasik surgery.
The lens is surgically implanted on top of the natural lens. It is a more invasive procedure than Lasik and thus may come with more risks. The procedure has to be done in a sterile surgical room.
The procedure costs about $3,000 to $4,000 per eye. Dr. Frank Rosenbaum of Rosenbaum Eye & Lasik Center says he has done three of the procedures in South America and has been eagerly looking forward to its approval in the United States. He says this is just the start of a new wave of this technology and more lenses will be approved by the FDA in the next few months.